Reuters logo
BRIEF-G1 Therapeutics And AstraZeneca Enter Clinical Trial Collaboration In Non-Small Cell Lung Cancer
November 28, 2017 / 12:16 PM / 18 days ago

BRIEF-G1 Therapeutics And AstraZeneca Enter Clinical Trial Collaboration In Non-Small Cell Lung Cancer

Nov 28 (Reuters) - G1 Therapeutics Inc:

* G1 THERAPEUTICS AND ASTRAZENECA ENTER CLINICAL TRIAL COLLABORATION IN NON-SMALL CELL LUNG CANCER

* - ‍FINANCIAL TERMS OF NON-EXCLUSIVE COLLABORATION HAVE NOT BEEN DISCLOSED​

* G1 THERAPEUTICS - ‍COLLABORATION TO EVALUATE ASTRAZENECA‘S EGFR TYROSINE KINASE INHIBITOR TAGRISSO IN COMBINATION WITH G1‘S ORAL CDK4/6 INHIBITOR G1T38​

* G1 THERAPEUTICS SAYS IT WILL SPONSOR AND CONDUCT A PHASE 1B/2 STUDY IN COLLABORATION WITH ASTRAZENECA IN PATIENTS WITH NSCLC​

* SAYS ‍PLANS TO INITIATE TRIAL IN Q1 OF 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below